Comparison between Asston Pharmaceuticals IPO and Shlokka Dyes IPO.
Asston Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Shlokka Dyes IPO is a SME Bookbuilding proposed to list at BSE SME.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | JSK Securities & Services Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Asston Pharmaceuticals IPO is up to ₹26.17 Cr whereas the issue size of the Shlokka Dyes IPO is up to ₹0.00 Cr. The final issue price of Asston Pharmaceuticals IPO is ₹123.00 per share and of Shlokka Dyes IPO is .
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹115.00 per share | |
| Issue Price (Upper) | ₹123.00 per share | |
| Issue Price (Final) | ₹123.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 21,28,000 shares | 65,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.17 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,28,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹26.17 Cr | up to ₹0.00 Cr |
Asston Pharmaceuticals IPO opens on Jul 09, 2025, while Shlokka Dyes IPO opens on . The closing date of Asston Pharmaceuticals IPO and Shlokka Dyes IPO is Jul 11, 2025, and , respectively.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Anchor Bid Date | Jul 08, 2025 | |
| Issue Open | Jul 09, 2025 | |
| Issue Close | Jul 11, 2025 | |
| Basis Of Allotment (Tentative) | Jul 14, 2025 | |
| Initiation of Refunds (Tentative) | Jul 15, 2025 | |
| Credit of Share (Tentative) | Jul 15, 2025 | |
| Listing date (Tentative) | Jul 16, 2025 | |
| Anchor Lockin End date 1 | Aug 13, 2025 | |
| Anchor Lockin End date 2 | Oct 12, 2025 |
Asston Pharmaceuticals IPO P/E ratio is 17.83, as compared to Shlokka Dyes IPO P/E ratio of .
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Asston Pharmaceuticals Limited Financial Information (Restated)Asston Pharmaceuticals Limited's revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| Shlokka Dyes Limited Financial Information (Restated Standalone)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.76 | 100.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹104.70 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.56% | 27.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 51.25% | 25.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.68 | 1.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.36% | 27.85% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Asston Pharmaceuticals IPO Retail Individual Investors (RII) are offered 7,46,000 shares while in Shlokka Dyes IPO retail investors are offered 7,46,000 shares. Qualified Institutional Buyers (QIB) are offered 4,25,000 shares in Asston Pharmaceuticals IPO and in Shlokka Dyes IPO.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Anchor Investor Reserveration | 6,35,000 shares | |
| Market Maker Reserveration | 1,13,000 shares | |
| QIB | 4,25,000 shares | |
| NII | 3,22,000 shares | |
| RII | 7,46,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 21,28,000 shares |
Asston Pharmaceuticals IPO subscribed 186.55x in total, whereas Shlokka Dyes IPO subscribed .
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| QIB (times) | 85.76x | |
| NII (times) | 353.14x | |
| Big NII (times) | 424.47x | |
| Small NII (times) | 210.85x | |
| RII (times) | 172.06x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 186.55x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
